Ozempic Vision Loss Lawsuits Combined in New Federal NAION Litigation

Federal courts have recently taken a significant step in the growing litigation involving Ozempic and similar diabetes and weight loss drugs. Lawsuits alleging that these medications – known as GLP-1 agonists – can cause sudden vision loss due to a condition known as non-arteritic anterior ischemic optic neuropathy (NAION) have now been consolidated into a new federal proceeding designed to coordinate the cases….
By: Hissey, Mulderig & Friend, PLLC